Evidence to use MRD after induction therapy of AML

Jacqueline Cloos, professor, PhD., Amsterdam University Medical Center and member of the AML group within The European LeukemiaNet (ELN) MRD Working Party presents the key take-home messages from the new guidelines on the use of MRD during the treatment of AML and how MRD can be used in clinical practice.